Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Pfizer
Pfizer
Bristol-Myers Squibb
Kaiser Permanente
OHSU Knight Cancer Institute
Indiana University
Second Life Therapeutics
AccSalus Biosciences, Inc.
Xynomic Pharmaceuticals, Inc.
The University of Hong Kong-Shenzhen Hospital
Convalife (Shanghai) Co., Ltd.